Leukaemia (all subtypes combined) statistics
- 8,616 people in the UK were diagnosed with leukaemia (all subtypes combined) in 2011.
- There were 4,807 deaths from leukaemia (all subtypes combined) in the UK in 2012.
- 46% of adult leukaemia (all subtypes combined) patients (48% of men and 44% of women) diagnosed in 2010-2011 in England and Wales are predicted to survive ten or more years.
- 15% of leukaemia (all subtypes combined) cases each year in the UK are linked to major lifestyle and other risk factors.
Stats, info and publications
The latest statistics available for leukaemia (all subtypes combined) in the UK are; incidence 2011, mortality 2012 and survival 2010-2011. Find out why these are the latest statistics available.
The ICD codes for leukaemia are ICD-10 C91-C95.
The term 'leukaemia' covers cancers of the white blood cells and bone marrow. Statistics for the four main subtypes of leukaemia are also provided: acute lymphoblastic leukaemia, chronic lymphocytic leukaemia, acute myeloid leukaemia and chronic myeloid leukaemia. These types differ substantially in their cellular origin and clinical behaviour. As such, it is important to recognise this when interpreting statistics on mortality from the group 'leukaemia' as a whole.
Survival statistics give an overall picture of survival and (unless otherwise stated) include all adults (15-99) diagnosed, at all ages, stages and co-morbidities. The survival time experienced by an individual patient may be much higher or lower, depending on specific patient and tumour characteristics. If you are a patient, please see our CancerHelp UK pages.
Specific questions and answers about some of Cancer Research UK's statistics and information and explanations on terminology used for statistics and reporting of cancer, and the methods used to calculate some of the statistics are also available.
We would like to acknowledge the essential work of the cancer registries in the United Kingdom and Ireland Association of Cancer Registries, without which there would be no data.
Question about cancer? Contact our information nurse team